Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Cedar Park Regional Medical Center located at 1401 Medical Pkwy, Cedar Park, TX, 78613 & includes data from NPIs 1376662296
*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,356 | 4,125 | ||||||||||
Surgical | 1,317 | 1,281 | ||||||||||
Non Surgical | 3,039 | 2,844 | ||||||||||
Orthopedics | 694 | 686 | ||||||||||
Cardiovascular | 693 | 642 | ||||||||||
Pulmonology | 670 | 632 | ||||||||||
General Medicine | 606 | 552 | ||||||||||
Urology | 528 | 517 | ||||||||||
Gastroenterology & Endocrinology | 477 | 453 | ||||||||||
Neurology | 231 | 212 | ||||||||||
General Surgery | 214 | 201 | ||||||||||
Oncology & Hematology | 100 | 90 | ||||||||||
Colorectal | 61 | 60 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 29 | 28 | ||||||||||
Psychiatry & Mental Disorders | 20 | 19 | ||||||||||
Obstetrics & Gynecology | 17 | 17 | ||||||||||
Spine | 14 | 14 |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 480: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Amputation Of Lower Limb For Endocrine, Nutritional And Metabolic Disorders | ||||||||||||
DRG 617: AMPUTATION OF LOWER LIMB FOR ENDOCRINE, NUTRITIONAL AND METABOLIC DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 282: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peptic Ulcer | ||||||||||||
Cirrhosis And Alcoholic Hepatitis | ||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
Complications Of Treatment |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Male Pelvic Procedures | ||||||||||||
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Ureter Procedures | ||||||||||||
DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Bladder Procedures | ||||||||||||
DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cholecystectomy | ||||||||||||
DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 419: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||
DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 440: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 438: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
DRG 445: DISORDERS OF THE BILIARY TRACT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 444: DISORDERS OF THE BILIARY TRACT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
DRG 066: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
Other Disorders Of Nervous System |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peritoneal Adhesiolysis | ||||||||||||
DRG 336: PERITONEAL ADHESIOLYSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Extracranial Procedures | ||||||||||||
DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Endocrine, Nutritional And Metabolic Procedures | ||||||||||||
DRG 629: OTHER ENDOCRINE, NUTRITIONAL AND METABOLIC O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Skin, Subcutaneous Tissue And Breast Procedures |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
Respiratory Neoplasms |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Procedures For Obesity | ||||||||||||
DRG 621: O.R. PROCEDURES FOR OBESITY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Stomach, Esophageal And Duodenal Procedures |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcohol/Drug Abuse Or Dependence |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Texas Total Hospitalizations (Oct 2016 to Sep 2019) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical |